A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS) (Q28174751)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: May 2005)

Language	Label	Description	Also known as
English	A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)	scientific article (publication date: May 2005)

Statements

scholarly article

0 references

1 reference

based on heuristic

inferred from title

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS) (English)

0 references

0 references

0 references

antiphospholipid syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

G Finazzi

1

0 references

R Marchioli

2

0 references

V Brancaccio

3

0 references

P Schinco

4

0 references

F Wisloff

5

0 references

J Musial

6

0 references

F Baudo

7

0 references

M Berrettini

8

0 references

S Testa

9

0 references

A D'Angelo

10

0 references

G Tognoni

11

0 references

T Barbui

12

0 references

language of work or name

0 references

publication date

May 2005

0 references

Journal of Thrombosis and Haemostasis

0 references

3

0 references

5

0 references

848-53

0 references

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

2 references

https://api.crossref.org/works/10.1111/J.1538-7836.2005.01340.X

21 April 2017

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01340.X

21 January 2018

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2005.01340.X

21 April 2017

Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01340.X

21 January 2018

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01340.X

21 January 2018

Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01340.X

21 January 2018

Oral anticoagulation and risk of death: a medical record linkage study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01340.X

21 January 2018

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01340.X

21 January 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01340.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28174751&oldid=1579840169"